Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of October 17, 2021
Genetic variations in CD101 affect HIV risk
From the Lund lab, Vaccine and Infectious Disease Division, and the Partners in Prevention HSV/HIV Transmission Study
Tip Sheet: Cancer-busting broccoli sprout pills in space, trauma and healing among Indigenous people, how to boost HPV vaccinations
Summaries of recent Fred Hutch research findings and other news
Investigating the mechanisms of genitourinary syndrome of menopause
From the Fredricks lab, Vaccine and Infectious Disease Division, and Massachusetts General Hospital
HIV vaccine trials are complicated by the availability of PrEP
World AIDS Day 2020: Vaccine researchers still find ways to run trials amid growing use of HIV-prevention drugs
Fearless Science is ...
Hutch researchers take bold approaches to solving hard problems
Scientists discuss how the pandemic has changed their research
COVID-19 pushes Hutch panelists to apply expertise to tackle an epic scientific and public health challenge
Fred Hutch Evergreen Fund awards six grants to promising projects
Scientists receive up to $200K to boost research for projects deemed to have partnership potential
Computer model offers insights on COVID-19 super-spreading
New research compares transmission patterns of SARS-CoV-2 with those of influenza
Antibodies a hot topic in COVID-19 research
Hutch scientists tap their antibody expertise for new tests, treatments, vaccines
Validating antibody tests to determine SARS-CoV-2 seroprevalence
From the University of Washington and the Jerome lab, Vaccine and Infectious Disease Division
Q&A: Dr. Larry Corey at the center of COVID-19 vaccine research
Fred Hutch scientists will play key roles in 'harmonizing' clinical trials
Targeted single-cell RNA sequencing maximizes cellular information at a lower cost
From the Gottardo, Newell, and Prlic labs, Vaccine and Infectious Disease Division
Antiviral cytokines pick up T cell slack
From the Schiffer group, Vaccine and Infectious Disease Division
Immune surveillance triggers HIV reactivation
From the Hladik lab, Vaccine and Infectious Disease Division
Seattle area COVID-19 tests show infections declining
Trends in coronavirus test results suggest social distancing is working
Fine-tuning B cell responses
From the Taylor Lab, Vaccine and Infectious Disease Division
Multi-step HIV-1 vaccines
From the Vaccine and Infectious Disease Division and the Chan Zuckerberg Biohub.
Conference on gene therapy for HIV cures will highlight progress and challenges ahead
Dr. Robert Siliciano, keynote speaker, discovered why AIDS drugs alone cannot cure HIV
Two Irish microbiologists find their way, together, to Seattle
Microbiome experts Drs. Susan Bullman and Christopher Johnston join Fred Hutch
Infections in immune-compromised patients: 5 new frontiers
Infectious disease experts gather in Seattle to find solutions for patients with compromised immunity